secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2023-12-05T23:59:59+00:00
Accession:  0001493152-23-043743
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa Pharmaceuticals presents at MedInvest Oncology Conference on Dec 5, 2023
--------------------------------------------------------------------------------

- Dr. David Young, President R&D, presents virtually at MedInvest Oncology Conference on Dec 5, 2023.
- Presentation titled 'Next Generation Chemotherapy: Improved Treatment for More Patients' at 1:35 PM PT/4:35 PM ET.
- CEO George Ng attends in person and is available for Q&A and one-on-one meetings.
- Presentation uploaded to investor portal and made available on Processa's website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315223043743/0001493152-23-043743-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315223043743/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-043743

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer